Mechanisms of mineralocorticoid salt-induced hypertension and cardiac fibrosis.
about
The ubiquitous mineralocorticoid receptor: clinical implicationsBrain mineralocorticoid receptors in cognition and cardiovascular homeostasisVirtual screening as a strategy for the identification of xenobiotics disrupting corticosteroid actionRoles of aldosterone and oxytocin in abnormalities caused by sevoflurane anesthesia in neonatal ratsHigh-salt intake suppressed microRNA-133a expression in Dahl SS rat myocardiumTwo-pore domain potassium channels in the adrenal cortex.The multifaceted mineralocorticoid receptorMineralocorticoid receptors are present in skeletal muscle and represent a potential therapeutic target.Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients.Mineralocorticoid receptor agonists induce mouse aortic aneurysm formation and rupture in the presence of high saltFibrosis: a key feature of Fabry disease with potential therapeutic implicationsRU28318, an aldosterone antagonist, in combination with an ACE inhibitor and angiotensin receptor blocker attenuates cardiac dysfunction in diabetes.Mineralocorticoid receptor antagonizes Dot1a-Af9 complex to increase αENaC transcription.Salt, aldosterone and hypertension.Targeting the mineralocorticoid receptor in cardiovascular disease.Mineralocorticoid receptor and cardiac arrhythmia.The role of ENaC in vascular endothelium.A Case of Glucocorticoid Remediable Aldosteronism and Thoracoabdominal Aneurysms.Mineralocorticoid receptor antagonism treats obesity-associated cardiac diastolic dysfunction.Myeloid cells are capable of synthesizing aldosterone to exacerbate damage in muscular dystrophy.Mineralocorticoid Receptor and Aldosterone-Related Biomarkers of End-Organ Damage in Cardiometabolic Disease
P2860
Q26861721-255D2E3D-40E1-4786-A3B8-D25CB9C874D5Q26995642-FC7D6009-B5EA-435A-A464-7FB39399C4CFQ28484229-E6DADFE7-19A2-4AD0-813D-CEE3D978EC59Q30448544-38A1A4D7-D8D6-40C1-B9BF-B61FBD53C834Q33907885-7BAA740E-0CC8-4708-85F5-7EBF39DF0C49Q35597757-611C1C02-4370-4D5C-94EF-C9A916B911C8Q35906989-00077298-AB20-4D49-9D26-816795836B94Q36171304-A04DC6A1-F533-4F13-AC5F-33A40EFD5197Q36626365-985E8DBD-B1D0-4707-BF71-2BF76F5E64BFQ36999577-AD375A7D-DC59-414D-A10A-3211DA80F1CFQ37113004-0528CE87-0EEA-4150-9BD2-63FF33304381Q37166553-1760B1A8-ACC6-4BC4-8682-D002B68498C2Q37342099-E43EED1B-4481-4936-AD83-E65E2979CB3EQ38025537-DDF8ABF4-1042-48F0-80E9-9E85F2D14397Q38074488-BE68109C-C5D4-4C8D-9E19-5A495EB7E7C7Q38124345-659AF158-5376-4ACB-9AA5-B23E93A0F3F9Q38138894-24455F1F-1B85-42E3-92FD-14CFF39878F4Q38846419-95D67AB4-5214-4975-9A0C-8AC1F16F5AFDQ39514603-A4903F85-6F3C-4B75-B8AE-235F97B349EAQ45970224-7B3933A1-1240-4452-9003-1FF8D7937D29Q58722306-F301D145-6B87-4065-8E47-BF1F1ECF139A
P2860
Mechanisms of mineralocorticoid salt-induced hypertension and cardiac fibrosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Mechanisms of mineralocorticoid salt-induced hypertension and cardiac fibrosis.
@en
Mechanisms of mineralocorticoid salt-induced hypertension and cardiac fibrosis.
@nl
type
label
Mechanisms of mineralocorticoid salt-induced hypertension and cardiac fibrosis.
@en
Mechanisms of mineralocorticoid salt-induced hypertension and cardiac fibrosis.
@nl
prefLabel
Mechanisms of mineralocorticoid salt-induced hypertension and cardiac fibrosis.
@en
Mechanisms of mineralocorticoid salt-induced hypertension and cardiac fibrosis.
@nl
P1476
Mechanisms of mineralocorticoid salt-induced hypertension and cardiac fibrosis
@en
P2093
Amanda J Rickard
P304
P356
10.1016/J.MCE.2011.09.008
P577
2011-09-10T00:00:00Z